共 50 条
- [26] Efficacy and safety of anti-PD-1/PD-L1 combinations versus standard of care in cancer: a systematic review and meta-analysis. ONCOIMMUNOLOGY, 2021, 10 (01):
- [27] Is Therapeutic Drug Monitoring for Anti-tumour Necrosis Factor Agents in Adults With Inflammatory Bowel Disease Ready for Standard of Care? A Systematic Review and Meta-analysis JOURNAL OF CROHNS & COLITIS, 2020, 14 (08): : 1057 - 1065
- [30] Nephrotoxicity in patients with solid tumors treated with anti-PD-1/PD-L1 monoclonal antibodies: a systematic review and meta-analysis Investigational New Drugs, 2021, 39 : 860 - 870